Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The epithelial sodium channel (ENaC) is a membrane-bound, non-voltage-gated ion channel that is highly selective for sodium ions (Na+). The alpha subunit of ENaC is encoded by the *SCNN1A* gene and is considered essential for forming an active channel at the cell surface. It plays a critical role in the regulation of sodium and water homeostasis across epithelial tissues, particularly in the kidney, lung, colon, and sweat glands. Dysfunction or mutations affecting ENaC α can lead to disorders such as Liddle syndrome, cystic fibrosis, and pseudohypoaldosteronism type I.
Blocks ENaC activity by targeting the pore region formed by transmembrane domains.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epithelial Sodium Channel Alpha Subunit (ENaC α).